In this talk we will explore the application of Multiplexed Error-Robust Fluorescence in situ Hybridization (MERFISH) technology to decode spatially regulated disease drivers in human heart and kidney ...

Leveraging multiplexed error-robust fluorescence in situ hybridization (MERFISH) technology, Vizgen has developed MERSCOPE, a high-resolution platform for spatially profiling the transcriptome. This ...

Vizgen, the life science company visualizing biology to advance human health through the first complete solution for single-cell spatial genomics, today released its first freely available dataset, ...

Advances in genomics technology, from PCR to NGS through single-cell analysis, have been critical for deepening our understanding of biology, but without spatial context, a crucial aspect of biology ...

Leader in spatial multi-omics technologies launches new generation of MERFISH chemistry and bridges basic and translational research with new pathology-grade, clinically relevant biomarkers CAMBRIDGE, ...

A recent Nature study uses a combination of single-cell ribonucleic acid (scRNA)-sequencing and high-resolution multiplexed error-robust fluorescence in situ hybridization (MERFISH) to better ...

Vizgen releases new dataset generated by Vizgen’s MERSCOPE ™ which includes a high-resolution spatial map of GPCR and RTK expression within the mouse brain CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vizgen, ...